Who are Acadia Pharmaceuticals's decision-makers?
Acadia Pharmaceuticals's official leadership and governance pages are the safest source for named executives.
- Primary buyers
- Finance, IT, operations, security, product, or commercial leadership
- Company status
- Public company; Nasdaq: ACAD
- HQ
- San Diego, CA
- Category
- Neuroscience therapeutics
- Decision style
- Mid-market / scaled operating committee
- Best source
- Official leadership or IR page
- Acadia Pharmaceuticals executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- Acadia Pharmaceuticals finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, and budget discipline.
- Acadia Pharmaceuticals technology or operations leadershipTechnology, product, operations, or security leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operational-improvement purchases.
Who leads Acadia Pharmaceuticals?
Acadia Pharmaceuticals's named leaders should be verified directly on the company's official leadership, governance, or investor-relations page. The profile intentionally avoids invented executive emails and treats official contact routes as the safe default.
Who owns buying decisions at Acadia Pharmaceuticals?
The buying committee depends on the offer. Finance and procurement usually control commercial approval, while IT, security, product, operations, clinical, industrial, or field leaders shape requirements and vendor evaluation.
How should sellers map the account?
Start with headquarters and public leadership, then map functional owners by product area. Use job posts, partner announcements, security pages, engineering posts, and investor materials to identify the active initiative behind a buying cycle.
As of June 2026.Sources:Acadia Pharmaceuticals official websiteAcadia Pharmaceuticals investor relations or company newsBuiltWith public technology profile
Acadia Pharmaceuticals — frequently asked questions
